Financial Performance - The company's operating revenue for 2019 was CNY 1,247,341,573.24, representing a 124.70% increase compared to CNY 555,124,332.86 in 2018[15] - The net profit attributable to shareholders for 2019 was CNY 66,562,444.36, a 136.77% increase from CNY 28,112,269.71 in 2018[15] - The net cash flow from operating activities for 2019 was CNY 139,913,384.06, up 63.54% from CNY 85,553,434.72 in 2018[15] - The basic earnings per share for 2019 was CNY 0.44, an increase of 131.58% compared to CNY 0.19 in 2018[15] - Total assets at the end of 2019 were CNY 1,378,211,428.82, a 39.42% increase from CNY 988,516,197.59 at the end of 2018[15] - The net assets attributable to shareholders at the end of 2019 were CNY 604,817,969.10, an increase of 11.24% from CNY 543,698,499.20 at the end of 2018[15] - The company reported a weighted average return on equity of 11.59% for 2019, up from 5.28% in 2018[15] - The company achieved operating revenue of 1,247.34 million yuan in 2019, representing a year-on-year growth of 124.70%[66] - Net profit attributable to shareholders reached 66.56 million yuan, up 136.77% year-on-year, while net profit excluding non-recurring gains and losses was 63.05 million yuan, an increase of 129.75%[66] Dividend Distribution - The company plans to distribute a cash dividend of CNY 1 per 10 shares, totaling CNY 15,000,000, and to increase capital reserves by 2 shares for every 10 shares held[4] - In 2019, the company distributed a cash dividend of RMB 15,000,000, representing 22.54% of the net profit attributable to ordinary shareholders[146] - The total distributable profit for 2019 was RMB 200,122,905.85, after deducting the legal surplus reserve of RMB 1,409,644.36[147] - The cash dividend accounted for 100% of the total profit distribution for the year[147] - The cash dividend for 2018 was RMB 5,250,000, which was 18.68% of the net profit attributable to ordinary shareholders[146] Acquisitions and Investments - The company acquired 70% of Beijing Jinyinlian International Supply Chain Management Co., enhancing its supply chain management capabilities in the printing and packaging industry[33] - The company made a significant equity investment of ¥121,607,900.00 to acquire 70% of Beijing Jinyinlian International Supply Chain Management[90] - The company acquired 70% of Beijing Jinyinlian, which contributed a net profit of RMB 12.51 million and a profit attributable to the parent company of RMB 8.43 million from July to December 2019[173] - The company has committed to ensuring that the performance of Holguo Si Lingkai will not be less than RMB 4,500 million for 2019 and a cumulative net profit of RMB 1.4 billion from 2018 to 2020[158] - For Beijing Jinyinlian, the performance commitments are set at RMB 2,000 million for 2019, RMB 2,200 million for 2020, and RMB 2,400 million for 2021, with a growth trend expected[158] Market Position and Growth - The pharmaceutical packaging market in China is expected to grow at an annual rate of over 10%, with the market size increasing from RMB 57.54 billion in 2012 to RMB 107.04 billion in 2018[26] - The company maintains a leading position in the domestic pharmaceutical folding carton packaging and pharmaceutical aluminum tube packaging sectors, with over 50% of the top 500 domestic pharmaceutical companies collaborating with the company[29] - The company has established long-term partnerships with 8 out of 11 global top 500 pharmaceutical companies, including Johnson & Johnson, Pfizer, and Bayer[29] - The company is positioned to benefit from the growing demand for environmentally friendly and smaller packaging solutions as consumer living standards improve[31] - The company is committed to continuous technological innovation and management improvements to enhance operational performance in the consumer goods packaging sector[32] Research and Development - The company obtained 8 new patents during the reporting period, bringing the total to 75 patents, including 4 invention patents[41] - Research and development expenses increased by 50.43% to 24.24 million yuan, reflecting a focus on technology innovation and product development[71] - The proportion of research and development investment to operating revenue decreased to 2.04% from 4.41% in the previous year, attributed to a substantial increase in revenue following acquisitions[75] - The company is committed to increasing R&D investment in big data tools to enhance its internet marketing services and provide targeted marketing solutions[115] - The company is focusing on enhancing its technological capabilities in data analysis and machine learning to support its marketing strategies[108] Risks and Challenges - The company has outlined potential risks in its future development outlook, which investors should be aware of[4] - The company is facing risks from rapid expansion in operational scale, which may challenge its management capabilities[132] - The fluctuation in raw material prices, particularly industrial packaging paper, poses a risk to the company's production costs and profitability[135] - The company will adjust its operational strategies and enhance market development efforts to mitigate risks from industry consolidation[130] - The company is closely monitoring national tax policies that could impact its net profit due to current tax incentives[134] Corporate Governance and Compliance - The company has committed to not transferring or entrusting the management of its shares for 36 months post-IPO[149] - The company will take legal measures to fulfill all commitments made during the IPO process and accept supervision from regulatory bodies[149] - The company has fulfilled all commitments related to the lock-up period for shares held by major shareholders[149] - The company will ensure that any necessary transactions with Xi'an Global Printing will adhere to market principles and be conducted fairly[151] - The company will not utilize its controlling shareholder status to seek any improper benefits[151] Operational Efficiency - The company is actively implementing a "two-integration" project to enhance digital and intelligent transformation across its operations[40] - The company has implemented an industry-leading information system, integrating OA, MES, and ERP systems, marking a significant step towards intelligent manufacturing and achieving Industry 4.0[121] - The company aims to build an integrated online service platform for supply chain management, combining internet, blockchain, and cloud computing technologies[126] - The company will strengthen internal controls and improve management efficiency to reduce risks associated with rapid growth[132] - The company is focusing on internet precision marketing, leveraging big data technology to enhance customer engagement and service delivery[45]

Financial Performance - Operating revenue for the reporting period reached ¥394,737,866.63, a significant increase of 237.15% year-on-year[8] - Net profit attributable to shareholders surged by 518.75% to ¥16,236,302.79 for the reporting period[8] - The net profit after deducting non-recurring gains and losses was ¥14,917,961.68, reflecting a 460.46% increase year-on-year[8] - Basic earnings per share rose by 450.00% to ¥0.11 for the reporting period[8] - The weighted average return on equity increased to 2.83%, up from 2.34% at the end of the previous year[8] - The net cash flow from operating activities was ¥92,717,328.05, an increase of 206.88% compared to the same period last year[8] - The company reported a significant increase in accounts receivable, which rose to CNY 311.85 million from CNY 156.73 million at the end of 2018[33] - The net profit for Q3 2019 reached ¥55,451,070.50, significantly up from ¥16,184,969.22 in Q3 2018, marking an increase of 242.5%[51] - The total profit for Q3 2019 was ¥60,765,279.85, compared to ¥18,648,806.27 in Q3 2018, indicating a growth of 225.5%[51] Assets and Liabilities - Total assets increased by 38.21% to ¥1,366,219,038.25 compared to the end of the previous year[8] - As of September 30, 2019, total assets amounted to CNY 1,366.22 million, an increase from CNY 988.52 million at the end of 2018[34] - The company's total liabilities increased to CNY 728.70 million from CNY 421.16 million, marking a rise of approximately 73%[36] - Total liabilities were CNY 421,162,402.48, with current liabilities at CNY 421,039,290.08 and non-current liabilities at CNY 123,112.40[68] - The company’s total liabilities to total assets ratio stands at approximately 42.6%[68] Shareholder Information - The total number of shareholders at the end of the reporting period was 10,957[12] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group, holds 46.25% of the shares[12] - The company distributed cash dividends of ¥5,250,000, amounting to ¥0.35 per share, as part of its 2018 annual equity distribution[20] Research and Development - Research and development expenses increased by 50.75% to ¥16,572,229.22, up from ¥10,992,989.93, indicating a focus on innovation[17] - Research and development expenses for Q3 2019 were CNY 6.33 million, up from CNY 4.76 million in the previous year, reflecting an increase of approximately 32.9%[42] - Research and development expenses increased to ¥9,190,054.55 from ¥8,505,073.82, representing a rise of 8.1% year-on-year[54] Cash Flow - The cash flow from operating activities increased by 100.99% to ¥875,109,690.52, compared to ¥435,405,271.79 in the previous year[17] - The net cash flow from operating activities for Q3 2019 was ¥76,349,775.78, a decrease from ¥80,225,064.82 in Q3 2018[58] - Total cash inflow from operating activities was ¥888,023,316.50, compared to ¥438,717,840.96 in the previous year, indicating a significant increase[58] - The net cash flow from financing activities improved to ¥76,009,774.63 from -¥28,920,274.13 in Q3 2018[59] Acquisitions and Investments - The company completed the acquisition of a 70% stake in Beijing Jinyinlian International Supply Chain Management Co., Ltd. in July 2019[20] - The acquisition of a 70% stake in Beijing Jinyinlian International Supply Chain Management Co., Ltd. has been completed, positively impacting the company's net profit[25] - The company plans to establish a new subsidiary, Xi'an Global Ruilian Information Technology Co., Ltd., in collaboration with Beijing Aisruit Technology Co., Ltd.[22] Operational Costs - The net profit margin improved significantly, with operating costs rising to ¥707,509,463.99, reflecting a 142.56% increase from ¥291,684,882.29[17] - Total operating costs for Q3 2019 were CNY 372.18 million, up from CNY 115.36 million in the previous year, indicating an increase of about 222.5%[42] - The company reported a decrease in operating costs to ¥219,757,466.66 from ¥227,916,658.41, a reduction of 3.9%[53] Financial Ratios and Metrics - The company reported a financial expense of CNY 3,009,753.46 for the third quarter, significantly higher than CNY 1,052,360.87 in the previous year, indicating an increase of approximately 185.5%[46] - The total equity attributable to shareholders increased to CNY 582.12 million from CNY 543.70 million, showing a growth of about 7.1%[36]

Financial Performance - The company's operating revenue for the first half of 2019 was CNY 446,805,492.42, representing a 79.84% increase compared to CNY 248,451,302.71 in the same period last year[18]. - The net profit attributable to shareholders of the listed company reached CNY 28,428,949.31, a 110.90% increase from CNY 13,479,984.70 year-on-year[18]. - The net profit after deducting non-recurring gains and losses was CNY 26,945,748.00, up 116.03% from CNY 12,473,287.90 in the previous year[18]. - The basic earnings per share increased to CNY 0.19, reflecting a growth of 111.11% compared to CNY 0.09 in the same period last year[18]. - The total assets at the end of the reporting period were CNY 1,049,795,288.58, a 6.20% increase from CNY 988,516,197.59 at the end of the previous year[18]. - The company reported a net cash flow from operating activities of -CNY 16,367,552.27, a decline of 132.73% compared to CNY 50,012,049.11 in the previous year[18]. - The weighted average return on net assets was 5.10%, an increase of 2.53 percentage points from 2.57% in the same period last year[18]. - The company reported a significant increase in cash flow from financing activities, amounting to RMB 54.23 million, due to new loans and financing[49]. - The company reported a total profit of 39,100 yuan from leasing properties and land for office and production purposes[113]. Strategic Focus and Expansion - The company plans to focus on the pharmaceutical packaging sector, providing integrated packaging solutions including design, production, and logistics[26]. - The company is expanding into the consumer goods packaging sector, leveraging its advantages in pharmaceutical packaging to cover various fields such as fast-moving consumer goods and medical devices[27]. - The company is focusing on expanding its consumer packaging business, driven by a strong trend in consumption upgrades, with retail sales exceeding 38 trillion yuan in 2018[33]. - The company is actively expanding into the consumer goods packaging sector while maintaining a focus on pharmaceutical packaging[45]. - The company aims to enhance its operational strategies and market expansion through targeted investments and acquisitions[126]. Acquisitions and Investments - The company has acquired 70% of Beijing Jinyinlian International Supply Chain Management Co., enhancing its supply chain management capabilities and integrating industry resources[30]. - The company has completed the acquisition of Holguo Ke Network Technology Co., which allows it to enter the "Internet new economy" sector and enhance customer service[28]. - The company has invested in 18 new patents during the reporting period, bringing the total to 101 patents granted[39]. - The company made a significant investment of ¥121,607,900.00 during the reporting period, marking a 100% increase compared to the previous year[58]. - The company acquired 70% of Holguozi Linkai Network Technology Co., Ltd., resulting in goodwill of 108 million yuan on the consolidated balance sheet[89]. Financial Health and Risks - The company faces risks from national policy adjustments affecting the pharmaceutical and consumer goods packaging sectors, which may impact operational performance[79]. - The company is closely monitoring raw material price fluctuations, particularly in industrial packaging paper, which significantly affects production costs[86]. - The accounts receivable balance at the end of the reporting period is 209.02 million CNY, posing a risk of bad debts if customer conditions deteriorate[88]. - The company aims to reduce the proportion of accounts receivable to operating income to improve cash flow and mitigate risks associated with accounts receivable[88]. - The company plans to enhance internal management and operational efficiency to mitigate risks from policy changes and industry consolidation[79]. Research and Development - Research and development investment increased by 64.48% to RMB 10.25 million, primarily due to the addition of new subsidiaries[49]. - The company is increasing R&D investment and market expansion efforts to improve core competitiveness amid intense market competition in the internet marketing sector[81]. - The company is committed to keeping pace with technological advancements and enhancing R&D to transition from traditional to intelligent manufacturing in the packaging industry[83]. Social Responsibility and Community Engagement - The company has actively engaged in various poverty alleviation projects, focusing on employment and education[125]. - The company reported a total of 112,100 yuan in wages and 6,000 yuan in hardship subsidies for seven identified impoverished employees[121]. - The company has invested a total of 11.21 million yuan in poverty alleviation efforts, helping 7 registered impoverished individuals to escape poverty[122]. - In the second half of 2019, the company plans to enhance its employment poverty alleviation initiatives and actively participate in targeted poverty alleviation projects[124]. - The company will continue to fulfill its social responsibilities effectively in poverty alleviation efforts throughout 2019[125]. Shareholder Information - The company did not distribute cash dividends or issue bonus shares for the half-year period[93]. - The company’s annual shareholders' meeting had a participation rate of 74.54%[92]. - The total number of common shareholders at the end of the reporting period is 11,464[135]. - The largest shareholder, Shaanxi Pharmaceutical Holdings Group, holds 46.25% of shares, totaling 69,375,000 shares[135]. - The second largest shareholder, Hong Kong Original Stone International, holds 18.75% of shares, totaling 28,125,000 shares[135]. Compliance and Governance - The half-year financial report has not been audited[97]. - The company has fulfilled all commitments made by its actual controllers and shareholders during the reporting period[94]. - The company will take legal measures to fulfill all commitments related to its initial public offering[96]. - The company has not experienced any bankruptcy reorganization matters during the reporting period[98]. - The company has no significant litigation or arbitration matters during the reporting period[99].

Financial Performance - The company's operating revenue for 2018 was ¥555,124,332.86, representing a 26.68% increase compared to ¥438,211,497.30 in 2017[14] - The net profit attributable to shareholders for 2018 was ¥28,112,269.71, up 24.34% from ¥22,608,687.67 in 2017[14] - The net cash flow from operating activities increased by 64.80% to ¥85,553,434.72 in 2018, compared to ¥51,911,950.44 in 2017[14] - Basic earnings per share rose to ¥0.19 in 2018, a 26.67% increase from ¥0.15 in 2017[14] - Total assets at the end of 2018 reached ¥988,516,197.59, marking a 29.19% increase from ¥765,141,149.28 at the end of 2017[17] - The net assets attributable to shareholders increased by 4.81% to ¥543,698,499.20 at the end of 2018, compared to ¥518,725,135.60 at the end of 2017[17] - The weighted average return on net assets for 2018 was 5.28%, an increase from 4.37% in 2017[17] - The company reported a diluted earnings per share of ¥0.19 for 2018, consistent with the basic earnings per share[14] Business Expansion and Strategy - The company has expanded its business scope to include internet advertising and e-commerce services, enhancing its market presence[14] - The company is expanding into consumer packaging, covering sectors such as dairy products, medical devices, health foods, fine chemicals, and electronic products[28] - The company has entered the "Internet+" business model by acquiring Holguo Network Technology Co., enhancing its mobile internet services and increasing customer engagement[29] - The company aims to continuously explore and expand its consumer packaging business, capitalizing on the growing market demand and improving living standards[33] - The company is focusing on internet precision marketing services, leveraging big data technology to enhance marketing strategies and optimize client engagement[34] - The company plans to integrate industry resources through supply chain management, creating an "Internet+" platform that encompasses information flow, logistics, and financial services[103] Research and Development - Research and development expenses increased by 117.77% to CNY 16.11 million, driven by an increase in R&D projects[67] - The number of R&D personnel rose by 32.26% to 123, representing 13.52% of the total workforce[71] - The company has completed industry-leading foundational software development for big data tools, which will support its ongoing strategy for data integration and upgrades[34] - The company obtained 11 new patents during the reporting period, bringing the total to 67, maintaining its leading position in the industry[39] Acquisitions and Investments - The company acquired 70% of Holguo Lenkai Network Technology Co., Ltd., marking a significant step in its "Internet Plus" strategic layout[46] - The company acquired 70% of Lingkai Network Technology, which contributed a net profit of CNY 7,790,800 from October to December 2018, accounting for 19.40% of the net profit attributable to shareholders[62] - The company acquired a 70% stake in Horgos Lingkai Network Technology Co., Ltd. for ¥131,860,000.00, with expected net profit not less than ¥45 million for 2018[84] Cash Flow and Financial Management - Cash and cash equivalents totaled 154.83 million yuan, reflecting a 16.11% increase, which is within a normal range[35] - Accounts receivable increased by 36.36% to 211.60 million yuan, driven by increased sales and the inclusion of newly acquired subsidiaries[35] - Investment cash outflow increased by 54.13% to CNY 97.26 million, mainly due to the acquisition of Lingkai Network Technology[74] - Financing cash inflow grew by 60.81% to CNY 198.71 million, attributed to increased borrowings[73] Corporate Governance and Compliance - The company improved its internal control system in 2018, enhancing governance and operational efficiency[48] - The company has committed to ensuring compliance with market principles in all necessary transactions with its subsidiaries, adhering to fair pricing standards[141] - The company has taken measures to ensure proper information disclosure and will accept supervision from regulatory bodies and investors[141] Social Responsibility and Environmental Compliance - The company actively fulfilled its corporate social responsibilities, focusing on sustainable development and stakeholder engagement[173] - In 2018, the company contributed a total of 27.88 million RMB towards poverty alleviation efforts[177] - The company strictly adheres to environmental protection regulations and has implemented a monitoring system for pollution factors[182] - The company reported no significant environmental incidents and is not classified as a key pollutant discharge unit[179] Shareholder Information and Dividends - The company plans to distribute a cash dividend of ¥0.35 per 10 shares, based on a total of 150,000,000 shares[4] - The cash dividend for 2018 represents 18.68% of the net profit attributable to the company's ordinary shareholders, which was RMB 28,112,269.71[128] - The total distributable profit available for shareholders in 2018 was RMB 192,686,106.64, with the cash dividend constituting 100% of the profit distribution[128] Risks and Challenges - The company faces risks from national policy adjustments, particularly in the pharmaceutical and consumer goods sectors, which could impact its operational status[110] - The company has a significant accounts receivable balance of 170.65 million yuan, which poses a risk of bad debts if clients experience adverse financial changes[116] - The company acquired a 70% stake in Horgos Linkai Network Technology Co., Ltd., which may lead to goodwill impairment risks in the future[118]

Financial Performance - The company's revenue for Q1 2019 was ¥190,225,091.88, representing a 58.06% increase compared to ¥120,351,719.51 in the same period last year[8] - Net profit attributable to shareholders was ¥14,058,482.68, a 99.39% increase from ¥7,050,587.09 year-on-year[8] - The basic earnings per share increased by 125.00% to ¥0.09 from ¥0.04 in the previous year[8] - The company's operating revenue increased by 58.06% year-on-year, reaching ¥190,225,091.88[16] - Net profit for the current period was ¥17,112,464.19, compared to ¥6,671,583.69 in the previous period, reflecting a growth of approximately 156%[39] - The company reported a total comprehensive income for the current period of ¥17,112,464.19, compared to ¥6,671,583.69 in the previous period, indicating a growth of approximately 156%[40] - Operating profit for the current period was ¥18,580,343.66, an increase from ¥8,273,353.11, marking a growth of about 125%[39] Cash Flow - The net cash flow from operating activities decreased by 54.73% to ¥14,361,392.20, down from ¥31,720,488.00 in the same period last year[8] - Total cash inflow from operating activities was ¥233,213,919.37, up from ¥135,798,013.11, representing an increase of 71.8% year-over-year[47] - Cash outflow from operating activities totaled ¥218,852,527.17, compared to ¥104,077,525.11 in the previous year, indicating a rise of 110.5%[47] - The net cash flow from investing activities was -¥18,263,755.71, worsening from -¥1,536,158.60 in the same period last year[48] - The net cash flow from financing activities was -¥6,461,277.45, compared to -¥31,395,392.51 in Q1 2018, showing an improvement[48] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,012,364,961.97, a 2.41% increase from ¥988,516,197.59 at the end of the previous year[8] - Current liabilities rose slightly to CNY 428,479,013.38 from CNY 421,039,290.08, an increase of about 1.0%[30] - The company's cash and cash equivalents decreased to CNY 76,547,086.44 from CNY 99,711,569.66, a decline of approximately 23.2%[33] - Total liabilities increased to CNY 428,602,125.78 from CNY 421,162,402.48, an increase of approximately 1.0%[30] - The company’s fixed assets decreased to CNY 269,252,388.26 from CNY 274,538,573.54, a decline of about 1.0%[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,273[11] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group, held 46.25% of the shares, totaling 69,375,000 shares[11] - The total equity attributable to shareholders increased to CNY 557,262,971.49 from CNY 543,698,499.20, an increase of about 2.5%[31] Investments and Acquisitions - The company completed the acquisition of a 70% stake in Horgos Linkai Network Technology Co., Ltd.[18] - The company plans to establish a new subsidiary in collaboration with Beijing Aisruit Technology Co., Ltd. and Beijing Jinyinlian International Supply Chain Management Co., Ltd.[18] - The company received cash from investment income amounting to ¥1,416,021.99, marking a 100% increase year-on-year[16] - Investment income from joint ventures and associates was ¥2,796,919.27, compared to ¥2,156,575.00 in the previous period, indicating an increase of about 30%[37] Operational Costs - The operating cost rose by 60.75% year-on-year, totaling ¥152,869,458.65[16] - Total operating costs amounted to ¥174,442,420.32, up from ¥114,166,903.36, indicating an increase of about 53%[37] - Cash paid for purchasing fixed assets increased by 85.99% year-on-year, totaling ¥4,932,477.70, due to the acquisition of key production equipment[16] Research and Development - Research and development expenses increased to ¥4,624,111.38 from ¥3,805,334.61, showing a rise of approximately 21%[37] Future Outlook - The net profit for the first half of 2019 is expected to increase by over 50% year-on-year[20] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[39]

Financial Performance - The company's operating revenue for 2018 was ¥555,124,332.86, representing a 26.68% increase compared to ¥438,211,497.30 in 2017[16] - The net profit attributable to shareholders for 2018 was ¥28,112,269.71, up 24.34% from ¥22,608,687.67 in the previous year[16] - Basic earnings per share rose to ¥0.19, a 26.67% increase from ¥0.15 in 2017[16] - The weighted average return on net assets for 2018 was 5.28%, an increase from 4.37% in 2017[17] - The company achieved double-digit growth in both revenue and profit during the reporting period despite market challenges[47] - The company reported a net profit of 7.79 million for the period after acquiring 70% of Horgos Linkai Network Technology, contributing 5.45 million to the parent company's net profit[98] - The company’s net profit for 2018 was RMB 23,167,860.11, with a legal reserve of RMB 2,316,786.01 set aside, leaving a distributable profit of RMB 192,686,106.64[127] Cash Flow and Assets - The net cash flow from operating activities increased by 64.80% to ¥85,553,434.72 in 2018, compared to ¥51,911,950.44 in 2017[16] - Total assets at the end of 2018 reached ¥988,516,197.59, marking a 29.19% increase from ¥765,141,149.28 at the end of 2017[17] - Cash and cash equivalents totaled 154.83 million yuan, reflecting a 16.11% increase, which is within a normal range[35] - Accounts receivable increased to 211.60 million yuan, a rise of 36.36%, driven by increased sales and the addition of a newly consolidated subsidiary[35] - The company’s cash and cash equivalents at year-end were ¥154,833,478.74, which is 15.66% of total assets, down from 17.43% the previous year[77] Investments and Acquisitions - The company acquired 70% of Holguo Lenkai Network Technology Co., Ltd., marking a significant step in its "Internet Plus" strategic layout[46] - The company acquired 70% of Lingkai Network Technology, which contributed a net profit of CNY 7,790,800 from October to December 2018, accounting for 19.40% of the net profit attributable to shareholders[62] - The company has committed a total investment of RMB 16.88 billion, with a cumulative investment of RMB 13.63 billion, representing an investment progress of 80.83%[92] Research and Development - Research and development expenses increased by 117.77% to CNY 16.11 million, driven by an increase in R&D projects[67] - The number of R&D personnel rose by 32.26% to 123, representing 13.52% of the total workforce[71] - The company obtained 11 new patents during the reporting period, bringing the total to 67, including 3 invention patents[39] Market Position and Strategy - The company maintains a leading position in the domestic pharmaceutical folding carton packaging and pharmaceutical aluminum tube packaging sectors, continuously expanding into other pharmaceutical packaging areas[27] - The company is expanding into consumer packaging, covering sectors such as dairy products, medical devices, health foods, fine chemicals, and electronic products[28] - The company aims to continuously explore and expand its market share in the consumer packaging sector, driven by rising living standards and increasing demand for environmentally friendly packaging solutions[33] - The company is actively pursuing "Internet+" strategies through the acquisition of Lingkai Network, enhancing its capabilities in big data and advertising technology[69] Environmental and Social Responsibility - The company has made significant investments in environmental protection, including upgrading VOCs waste gas treatment equipment and installing online monitoring devices for volatile organic compounds[48] - The company actively fulfilled its corporate social responsibilities, focusing on sustainable development and stakeholder engagement[170] - In 2018, the company contributed a total of 27.88 million RMB towards poverty alleviation efforts[174] Risks and Challenges - The company faces risks from national policy adjustments affecting the pharmaceutical and consumer goods sectors, which could impact its operational performance[108] - The company is also exposed to risks from intensified industry consolidation and competition in the printing and packaging market[109] - The company faces risks related to the fluctuation of raw material prices, particularly for white cardboard and whiteboard paper, which are closely tied to the consumer goods industry[113] Shareholder Information - The company has a total of 150 million shares, with 48.75% being limited shares and 51.25% being unrestricted shares[185] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group Co., Ltd., holds 46.25% of the shares, totaling 69,375,000 shares[187] - The company has not conducted any repurchase transactions among the top 10 ordinary shareholders during the reporting period[189] Corporate Governance - The company has strengthened its internal control system to improve governance and operational efficiency[48] - The company has committed to ensuring that measures to fill the earnings per share are effectively implemented, including constraints on executive consumption behaviors and linking compensation systems to performance measures[130] - The company has established a commitment to adhere to regulatory requirements for information disclosure, accepting supervision from regulatory bodies and investors[138]

西安环球印务股份有限公司 2018 年第三季度报告正文 2018 年 10 月 西安环球印务股份有限公司 2018 年第三季度报告正文 证券代码：002799 证券简称：环球印务 公告编号：2018-068 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人李移岭、主管会计工作负责人林蔚及会计机构负责人(会计主管 人员)夏美莹声明：保证季度报告中财务报表的真实、准确、完整。 2 西安环球印务股份有限公司 2018 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 812,399,625.62 | | 765,141,149.28 | 6.18% | | 归属于上市公司股东的净资产 | 534,830,4 ...

Financial Performance - The company's operating revenue for the first half of 2018 was CNY 248,451,302.71, representing a 12.24% increase compared to CNY 221,364,052.60 in the same period last year[15]. - The net profit attributable to shareholders was CNY 13,479,984.70, up 4.07% from CNY 12,953,331.38 year-on-year[15]. - The net cash flow from operating activities surged by 853.51% to CNY 50,012,049.11, compared to CNY 5,245,033.73 in the previous year[15]. - Total assets increased by 9.30% to CNY 836,272,988.21 from CNY 765,141,149.28 at the end of the previous year[15]. - The company reported a decrease of 1.49% in net profit after deducting non-recurring gains and losses, totaling CNY 12,473,287.90 compared to CNY 12,662,437.92 in the previous year[15]. - The weighted average return on net assets was 2.57%, slightly up from 2.48% in the previous year[15]. - The operating cost increased by 13.66%, reaching ¥199,082,997.02, up from ¥175,161,725.27 in the previous year[52]. - The company reported a significant increase in financial expenses by 229.66% to CNY 3,394,322.08, mainly due to new financing and increased interest expenses[58]. - The gross profit margin for the paper and paper products industry was 19.59%, showing a decrease of 0.96% year-on-year[58]. - The company reported a net profit of 50 million RMB for the first half of 2018, representing a year-on-year increase of 20%[97]. Strategic Focus and Expansion - The company plans to continue focusing on the pharmaceutical packaging sector while expanding into electronic product packaging, having established partnerships with major clients like Samsung and ZTE[24]. - The company aims to leverage its brand advantage in the pharmaceutical packaging industry to expand into the drug inner packaging materials sector, enhancing market synergy[25]. - The company plans to expand into the consumer goods packaging sector, driven by the increasing quality of life and consumption upgrades in the country, targeting health products, food, beverages, cosmetics, and other fast-moving consumer goods[29]. - The company aims to strengthen its position in the pharmaceutical packaging market while expanding into electronic products, health products, food, beverages, cosmetics, and other fast-moving consumer goods packaging sectors[45]. - The company has established production bases in Xi'an, Tianjin, and plans for the Yangtze River Delta region to enhance market responsiveness[45]. - The company aims to achieve strategic breakthroughs by focusing on the "5882" strategy, which includes developing eight hundred billion-level strong foundational projects and creating eight trillion-level industrial clusters[28]. Research and Development - The company has applied for 4 new patents, including 2 invention patents, maintaining its competitive edge in technology and innovation within the pharmaceutical packaging sector[36]. - A new research and development center is being established to enhance technological innovation and improve the application of new technologies and processes[46]. - Research and development expenses decreased by 9.73% to CNY 9,746,400.00 compared to CNY 10,796,586.65 in the previous year[58]. - Research and development expenses increased by 25% compared to the previous year, focusing on innovative printing technologies[97]. Cash Flow and Financial Management - Cash and cash equivalents increased by 29.90% to CNY 173.22 million, primarily due to increased sales receipts[32]. - Accounts receivable rose by 20.63% to CNY 149.90 million, reflecting sales growth during the reporting period[32]. - Inventory decreased by 2.35% to CNY 84.91 million, indicating stable operations without significant fluctuations[32]. - The company’s investment income was CNY 3,848,283.00, accounting for 24.83% of total profit[61]. - The company has temporarily used RMB 20 million of idle raised funds to supplement working capital, with a usage period not exceeding 12 months[72]. - The company has not sold any significant assets or equity during the reporting period[78]. Risks and Challenges - The company faces risks from rapid expansion, which may challenge its management capabilities in new market development and technology innovation[82]. - The printing industry is experiencing intensified competition and consolidation, which could impact the company's future strategic development if it slows down its expansion efforts[83]. - The company is exposed to risks from fluctuations in raw material prices, particularly for white cardboard and white board paper, which are critical to its cost structure[84]. - The company has a significant accounts receivable balance of 149.90 million RMB, accounting for 60.33% of its revenue, which poses a risk of bad debts[89]. Shareholder and Governance Commitments - The company does not plan to distribute cash dividends or issue bonus shares for the reporting period[4]. - The controlling shareholder has committed to unconditionally bear any costs arising from the company's obligations related to housing provident fund management, ensuring no economic losses to the company[96]. - The controlling shareholder has a lock-up commitment for 36 months post-listing, during which they will not transfer or manage shares of the company[96]. - The company has committed to not planning any major events such as asset restructuring or acquisitions in the next three months[102]. - The company has pledged to compensate for any economic losses incurred by investors due to non-fulfillment of commitments[102]. Social Responsibility and Environmental Measures - The company has implemented environmental protection measures, including new and upgraded equipment, achieving low pollution and low emissions goals[128]. - The company donated 12,000 yuan to support top students from impoverished rural households in Shaanxi Province as part of its social responsibility efforts[129].

Financial Performance - The company's operating revenue for Q1 2018 was ¥120,351,719.51, representing a 13.83% increase compared to ¥105,726,713.91 in the same period last year[8] - The net profit attributable to shareholders for Q1 2018 was ¥7,050,587.09, up 16.00% from ¥6,078,140.82 in the previous year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,110,086.92, reflecting a 16.97% increase from ¥6,078,589.36 year-on-year[8] - The basic earnings per share for Q1 2018 was ¥0.0470, an increase of 16.05% compared to ¥0.0405 in the previous year[8] - The net profit attributable to shareholders for the first half of 2018 is expected to range from ¥1,230.56 million to ¥1,424.86 million, reflecting a change of -5.00% to 10.00% compared to the same period last year[21] Cash Flow and Assets - The net cash flow from operating activities for Q1 2018 was ¥31,720,488.00, a significant improvement from a negative cash flow of ¥10,845,212.33 in the same period last year[8] - Total assets at the end of Q1 2018 amounted to ¥789,493,080.52, which is a 3.18% increase from ¥765,141,149.28 at the end of the previous year[8] - The net assets attributable to shareholders at the end of Q1 2018 were ¥525,777,002.50, up 1.36% from ¥518,725,135.60 at the end of the previous year[8] - Accounts receivable decreased by 32.05% to ¥21,001,563.59 due to increased bill settlements during the period[15] - Cash received from the disposal of fixed assets amounted to ¥1,115,838.00, indicating asset liquidation activity[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,647[11] - The company did not report any overdue commitments from shareholders or related parties during the reporting period[19] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[23] Expenses and Liabilities - Financial expenses rose by 137.80% to ¥1,305,776.74 mainly due to increased interest expenses[15] - The company repaid bank loans totaling ¥40,000,000.00, an increase of 166.67% compared to the previous period[16] Strategic Initiatives - The company plans to acquire 100% equity of three target assets, including Beijing Jinyinlian International Supply Chain Management Co., Ltd.[17] Non-Recurring Items - The company reported non-recurring gains and losses totaling -¥59,499.83 for the period[9] - Prepayments increased by 74.96% to ¥2,843,642.19 primarily due to higher advance payments to suppliers[15] Return on Equity - The weighted average return on equity for Q1 2018 was 1.35%, an increase of 0.18% from 1.17% in the previous year[8]

Financial Performance - The company's operating revenue for 2017 was ¥438,211,497.30, representing a 13.09% increase compared to ¥387,502,466.93 in 2016[16] - The net profit attributable to shareholders for 2017 was ¥22,608,687.67, a decrease of 15.63% from ¥26,795,985.32 in 2016[16] - The net cash flow from operating activities increased by 25.80% to ¥51,911,950.44 in 2017, up from ¥41,266,281.93 in 2016[16] - The basic earnings per share for 2017 was ¥0.15, down 16.67% from ¥0.18 in 2016[16] - Total assets at the end of 2017 were ¥765,141,149.28, reflecting a 10.47% increase from ¥692,618,350.12 at the end of 2016[16] - The company's net assets attributable to shareholders were ¥518,725,135.60 at the end of 2017, a slight increase of 0.51% from ¥516,097,846.94 in 2016[16] - The weighted average return on equity for 2017 was 4.37%, down from 6.42% in 2016[16] Revenue and Sales - Total revenue for 2017 reached ¥438.21 million, a year-on-year increase of 13.09% compared to ¥387.50 million in 2016[57] - The paper and paper products industry accounted for ¥435.38 million, representing 99.35% of total revenue, with a year-on-year growth of 13.05%[57] - The sales volume of pharmaceutical and other paper boxes increased by 15.17% to 363,405.97 million units in 2017, while production volume rose by 13.06%[61] - The revenue from corrugated boxes surged by 56.06% to ¥35.36 million, with sales volume increasing by 42.57% to 1,302 million square meters[62] - The Northeast region saw a revenue increase of 22.83% to ¥46.52 million, while the Southwest region experienced an 80.34% growth to ¥33.23 million[59] Expenses and Costs - Gross margin for the paper and paper products industry was 19.25%, a decrease of 1.59% from the previous year[60] - Sales expenses rose by 23.32% to ¥29.14 million, while management expenses increased by 14.02% to ¥28.17 million[69] - Financial expenses decreased by 57.98% to ¥2.70 million, primarily due to reduced interest expenses from loan repayments[69] Investments and R&D - The company's R&D investment amounted to ¥20,451,271.39, representing a 7.01% increase compared to ¥19,112,238.06 in the previous year[75] - The proportion of R&D investment to operating revenue decreased to 4.67% from 4.93% year-on-year, a change of -0.26%[75] - Long-term equity investments increased by 62.49% to CNY 66,133,100, mainly due to a CNY 25,000,000 investment in Shanghai Jiuxu Environmental Technology Co., Ltd.[34] Market Position and Expansion - The company maintains a leading position in the domestic pharmaceutical folding carton packaging market, with 65% of Fortune 500 pharmaceutical companies in China as clients[28] - The company is actively expanding into the electronic product packaging sector, having established partnerships with major clients such as Samsung and ZTE[26] - The market share of domestic smartphones has reached 76.8%, indicating significant growth potential in the electronic product packaging market[30] - The company plans to continue developing its consumer goods packaging business in response to national consumption upgrades and the growing health industry[31] Corporate Governance and Shareholder Relations - The company plans not to distribute cash dividends or issue bonus shares for the year[4] - The company’s profit distribution policy complies with its articles of association and has been approved by the shareholders' meeting[123] - The company will not transfer or repurchase shares held prior to the public offering for 36 months post-listing, with an automatic extension of the lock-up period if stock prices fall below the issue price[132] Risks and Challenges - The company faces risks from rapid expansion, including challenges in management and market development if it cannot adapt to increased operational demands[110] - The company is facing operational risks due to unclear national policies regarding electronic supervision codes in the pharmaceutical packaging industry[119] - The price of white cardboard and white board paper has increased by approximately 30% and 60% respectively in 2017, which could impact production costs and profitability if not managed effectively[113] Social Responsibility and Environmental Initiatives - The company actively engaged in social responsibility initiatives, including a donation of 10,000 yuan to a training center for children with autism[172] - The company is not classified as a key pollutant discharge unit and has implemented new environmental protection measures[174] Strategic Partnerships and Collaborations - The company has formed a strategic partnership with Jihong Co., Ltd. to leverage market resources and expand packaging market share[54] - The company has established a comprehensive ISO 9001 quality management system and has received recognition from clients and government departments for its sustainable development efforts[39] Changes in Management - The company has undergone a management change with the dismissal of the Deputy General Manager, Chang Peng, on November 30, 2017, due to work-related reasons[198] - Li Yiling, the current Chairman and Party Secretary, has been with the company since 2001, holding various positions including General Manager and Vice Chairman[199]